Cargando…
BIOMARKER STATUS PREDICTS FOR LOCAL CONTROL (LC) FOLLOWING SPINE STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH SPINAL METASTASES
Report of spine SBRT outcomes in NSCLC patients and impact of death-ligand 1 (PD-L1) status and epidermal growth factor (EGFR) mutation on LC. METHODS: 165 patients and 389 spinal segments were retrospectively reviewed. Primary endpoint was LF and secondary outcomes included overall survival (OS) an...
Autores principales: | Shor, Dana, Zeng, Kang Liang, Chen, Hanbo, Menjak, Ines, Atenafu, Eshetu, Tseng, Chia-Lin, Detsky, Jay, Larouche, Jeremie, Zhang, Beibei, Soliman, Hany, Maralani, Pejman, Myrehaug, Sten, Louie, Alexander V, Sahgal, Arjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337558/ http://dx.doi.org/10.1093/noajnl/vdad071.017 |
Ejemplares similares
-
STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SACRAL METASTASES: DEVIATION FROM RECOMMENDED TARGET VOLUME DELINEATION PREDICTS HIGHER RISK OF LOCAL FAILURE
por: Moore-Palhares, Daniel, et al.
Publicado: (2023) -
30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN
por: Moore-Palhares, Daniel, et al.
Publicado: (2023) -
Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021) -
Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)